MEDPRIN REGENERATIVE MEDICAL TECHNOLOGIES CO., LTD.

Medprin Regenerative Medical Technologies Co., Ltd.

Equities

301033

CNE100004NB8

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-23 pm EDT			5-day change	1st Jan Change
40.21 ^CNY	-2.71%		-3.76%	-7.65%

Apr. 24	Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 18	Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Medprin Regenerative Medical Technologies Co., Ltd. Approves Final Cash Dividend for the Year 2022, Payable on 01 June 2023

May 19, 2023 at 03:44 pm EDT

Medprin Regenerative Medical Technologies Co., Ltd. announced at annual general meeting held on May 18, 2023, the shareholders approved final cash dividend of CNY 2.00000000 per 10 (A shares) (tax included) for the year 2022.
Record date: 31 May 2023. Ex-date: 01 June 2023. Payment date: 01 June 2023.

Latest news about Medprin Regenerative Medical Technologies Co., Ltd.

Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 24	CI
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 18	CI
Tranche Update on Medprin Regenerative Medical Technologies Co., Ltd.'s Equity Buyback Plan announced on February 23, 2024.	Apr. 01	CI
Medprin Regenerative Medical Technologies Co., Ltd. announces an Equity Buyback for CNY 20 million worth of its shares.	Feb. 22	CI
Medprin Regenerative Medical Technologies Co., Ltd. authorizes a Buyback Plan.	Feb. 21	CI
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-18	CI
Certain A Shares of Medprin Regenerative Medical Technologies Co., Ltd. are subject to a Lock-Up Agreement Ending on 26-JUL-2023.	23-07-25	CI
Medprin Regenerative Medical Technologies Co., Ltd. Approves Final Cash Dividend for the Year 2022, Payable on 01 June 2023	23-05-19	CI
Medprin Regenerative Medical Technologies Co., Ltd. Proposes Profit Distribution of Cash Dividend for the Year 2022	23-04-27	CI
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-26	CI
Medprin Regenerative Medical Gets Marketing Nod in China for Craniofacial Fixation Plate	23-03-14	MT
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-26	CI
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-12	CI
Certain A Shares of Medprin Regenerative Medical Technologies Co., Ltd. are subject to a Lock-Up Agreement Ending on 26-JUL-2022.	22-07-25	CI
Medprin Regenerative Medical Technologies to Free Up 2.5% Stake For Trading	22-07-21	MT
Medprin Regenerative Medical Technologies Co., Ltd. Approves Profit Distribution Plan for 2021	22-05-13	CI
Medprin Regenerative Medical Technologies Co., Ltd. Announces Profit Distribution for 2021	22-04-21	CI
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-20	CI
Medprin Regenerative Medical Technologies Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-26	CI
Medprin Regenerative Medical Technologies Co., Ltd. has completed an IPO in the amount of CNY 250.048697 million.	21-07-15	CI
Medprin Regenerative Medical Technologies Co., Ltd. has filed an IPO.	21-02-02	CI

Chart Medprin Regenerative Medical Technologies Co., Ltd.

Duration

Period

Chart Medprin Regenerative Medical Technologies Co., Ltd.

More charts

Company Profile

Medprin Regenerative Medical Technologies Co Ltd is a China-based company principally engaged in the research and development, production and sales of high-performance implantable medical devices. The Company's implanted medical device products include artificial dura mater (spine) patch, cranio-maxillofacial repair products and absorbable hemostatic yarns. 3D printing equipment includes biological 3D printers, resin 3D printers and other related supporting components. Technical services include general technical services and scientific research services. The Company distributes its products both in the domestic market and to overseas markets.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-08-11 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Medprin Regenerative Medical Technologies Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

40.21

Average target price

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Medical Devices & Implants

	1st Jan change	Capi.
MEDPRIN REGENERATIVE MEDICAL TECHNOLOGIES CO., LTD.	-7.65%	367M
STRYKER CORPORATION	+12.05%	128B
SMITH & NEPHEW PLC	-9.24%	10.88B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+0.29%	8.76B
GLAUKOS CORPORATION	+36.99%	5.48B
INSPIRE MEDICAL SYSTEMS, INC.	-21.98%	4.72B
AXONICS, INC.	+8.02%	3.43B
ENOVIS CORPORATION	-10.32%	2.76B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-12.33%	2.06B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-13.53%	1.92B

Medical Devices & Implants